Radiation Oncology

Radiation therapy uses high-energy radiation to damage cancer cells' DNA and destroy their ability to divide and grow. It is delivered using linear accelerators, proton accelerators, metered cobalt-60 exposure, or brachytherapy where radioactive seeds are placed inside the patient on a temporary or permanent basis to kill cancer or relieve pain. The main radiation oncology society and annual conference is the American Society of Radiation Oncology (ASTRO).

ASTRO receives VA contract to develop cancer therapy quality measures

“This pioneering effort leverages evidence-based guidelines and the consensus of medical experts in a new and powerful way to optimize care for military veterans,” said Theodore L. DeWeese, MD, chair of ASTRO's board.

February 13, 2020
Cancer bell being rung by VA patient Anthony Thomas at Edward Hines Jr. VA Hospital. Read more https://news.va.gov/90427/cancer-patients-final-treatment-ends-victory-bell/

Experts say it may be time to stop ringing the ‘cancer bell’

This common gesture is meant to signal joy at the end of treatment, but it's producing the opposite effect for some oncology patients, according to a recent survey. 

January 24, 2020

ASTRO releases new radiation therapy guidelines to treat skin cancers

More than 5 million people are diagnosed with skin cancer in the U.S. each year, and an overwhelming majority are categorized as either basal or cutaneous squamous cell carcinoma.

December 10, 2019

ACR collaborates with ASTRO on updated radiation therapy guidelines

The American College of Radiology has teamed up with the American Society for Radiation Oncology (ASTRO) on updated radiation therapy parameters for clinicians.

October 23, 2019
update policy

ACR, ASTRO update radiation therapy practice parameters

In total, the groups released seven updated practice parameters that describe recommended procedures and considerations to safely administer radiation depending on practice area.

October 23, 2019

ASTRO 2019: How radiation after immunotherapy helps some NSCLC patients

Radiation boosts the immune system of patients with metastatic non-small-cell lung cancer (NSCLC) after they stop responding to immunotherapy, according to findings presented at the 2019 annual meeting of the American Society for Radiation Oncology (ASTRO).

September 18, 2019

ASTRO 2019: AI predicts when patients will experience radiation-related side effects

AI can predict when patients undergoing radiation treatment for head and neck cancer may lose significant weight or require a feeding tube, according to findings presented at the 2019 annual meeting of the American Society for Radiation Oncology (ASTRO).

September 17, 2019

ASTRO: AI predicts radiation side effects for cancer patients

A new machine learning approach can predict the negative side effects of radiation treatment in patients with head and neck cancers. The findings, presented at the American Society for Radiation Oncology (ASTRO) annual meeting, can help select patients who might need a more tailored care approach.

September 17, 2019